NEW YORK, July 20 (Reuters) - Healthcare company Bayer on Friday said it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the ...

Essure birth control was first approved in 2002. — -- U.S. regulators said they would review a popular birth control implant device at a panel this week following multiple complaints. The implant ...

WASHINGTON, D.C. (WPVI) -- A local congressman says the FDA grossly underestimated the harm caused by a contraceptive device. And he alleges the maker paid doctors kickbacks to recommend the device to ...

Last month, the FDA scheduled a September panel meeting to take a hard look at Bayer's controversial birth control device, Essure, after getting complaints of clinical trial fraud and serious side ...

Yesterday, the FDA announced that Essure, a popular sterilization implant, could have serious side effects and ordered Bayer to conduct new safety trials on the device. In addition, the FDA drafted a ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Federal health regulators plan to warn consumers more strongly about Essure, a contraceptive implant that has drawn thousands of complaints from women reporting chronic pain, bleeding and other health ...

PHILADELPHIA (WPVI) -- The FDA slapped new restrictions on the sale of a controversial birth control device on Monday. The agency said some women aren't being properly informed of the risks of Essure ...

Bayer AG said Thursday it will pay $1.6 billion to settle claims that its birth control device Essure causes serious health complications, the latest in a string of settlements by the German company ...

RALEIGH (WTVD) -- Essure, a popular form of birth control, was marketed in 2002 as a permanent birth control without surgery. But, according to the Food and Drug Administration, more than 4,700 ...

The FDA on April 9 restricted the sale and distribution of Bayer’s permanent birth control device Essure to ensure women are well-informed of the device’s risks before choosing the contraceptive ...

At the request of the Food and Drug Administration, Leverkusen, Germany-based Bayer will now add a box warning and patient decision checklist to the label of its permanent birth control device Essure.